Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of Prochieve 8% progesterone gel for prevention of preterm delivery in high-risk pregnant women
2005-003884-22Phase 3Completed
- Sponsor
- Columbia Laboratories
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in preterm birth comparing Prochieve 8% progesterone gel with Placebo (2 arms). Primary endpoint: Delivery at or before 32 0/7 weeks gestational age. Started Aug 2005; status: completed.
02
Drugs
progesterone
03
Conditions
preterm birth
Beyond the preview
Go deeper on 2005-003884-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003884-22.